
PharmaSGP Holding SE
PSG | F
Overview
Corporate Details
- ISIN(s):
- DE000A2P4LJ5
- LEI:
- 3912005CZ12PVVCIPT91
- Country:
- Germany
- Address:
- Lochhamer Schlag 1, 82166 Gräfelfing
- Website:
- https://pharmasgp.com/english/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
harmaSGP is a pharmaceutical company with a broad portfolio of leading, over-the-counter (OTC) drugs and other healthcare products. Our drugs are based on natural pharmaceutical active ingredients with documented efficacy and have virtually no known side effects. With our pharmacy-exclusive products, we have trusted brands in many relevant chronic indications that are leaders in their respective categories. The herbal-medicine Baldriparan®, is the leading OTC brand in Germany for natural valerian sleep aids. With the brands RubaXX® for rheumatic pain and Restaxil® for neuralgic pain (nerve pain), we are also the market leader for systemic, chemical-free OTC pain relievers. In addition, the products against sexual weakness, which are marketed under the brands DESEO® and NERADIN®, are the leading chemical-free products in their category in Germany. Since the launch of the first product from the current portfolio in Germany in 2012, we have successfully exported our business.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-14 12:00 |
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,315 additional shares…
|
English | 6.8 KB | |
2025-08-11 13:00 |
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 39,678 additional share…
|
English | 6.8 KB | |
2025-08-08 11:47 |
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 873 additional shares o…
|
English | 6.8 KB | |
2025-08-07 13:11 |
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,505 additional shares…
|
English | 6.8 KB | |
2025-08-06 16:16 |
Delisting Announcement
PharmaSGP Holding SE: Delisting of PharmaSGP shares from Frankfurt Stock Exchan…
|
English | 7.8 KB | |
2025-08-05 10:48 |
Director's Dealing
PharmaSGP Holding SE: Michael Rudolf, Tender of 4,169 shares within the public …
|
English | 5.9 KB | |
2025-08-04 13:58 |
Delisting Announcement
PharmaSGP Holding SE: Dr. Clemens Fischer, Tender of a total of 6,062 addition…
|
English | 6.6 KB | |
2025-07-28 17:04 |
Delisting Announcement
PharmaSGP Holding SE publishes joint reasoned statement of the Management Board…
|
English | 9.2 KB | |
2025-07-28 14:11 |
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of an additional total of 4,491 share…
|
English | 6.9 KB | |
2025-07-24 15:30 |
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, buy
|
English | 6.0 KB | |
2025-07-24 14:11 |
Delisting Announcement
FUTRUE GmbH submits request to implement squeeze-out of minority shareholders o…
|
English | 8.2 KB | |
2025-07-23 17:38 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.0 KB | |
2025-07-23 17:15 |
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 540 shares in PharmaSGP…
|
English | 6.6 KB | |
2025-07-18 11:57 |
Delisting Announcement
PharmaSGP Holding SE: Acceptance period for FUTRUE GmbHs public delisting tende…
|
English | 7.2 KB | |
2025-07-11 08:01 |
Earnings Release
PharmaSGP Holding SE adjusts its revenues forecast for the full year 2025
|
English | 8.2 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2024-11-25 | FUTRUE GmbH | Close relation | Buy | None | 12,145,250.00 EUR |
2022-10-05 | MMI Leisure & Capital Management GmbH | Close relation | Buy | None | 125,383.20 EUR |
2022-10-05 | Hillen, Ingo | Board | Buy | None | 1,048.00 EUR |
2022-10-05 | MMI Leisure & Capital Management GmbH | Close relation | Buy | None | 26.60 EUR |
2022-05-30 | Wittig, Dr. Thomas | Supervisory board | Buy | None | 138,953.80 EUR |
2022-05-30 | Schröter, Jasmin | Close relation | Buy | None | 119,660.00 EUR |
2022-05-30 | Simon-Schröter, Dr. Wolfram | Other | Buy | None | 10,040.00 EUR |
2022-04-25 | FUTRUE GmbH | Close relation | Buy | None | 208,180.53 EUR |
2022-04-25 | MMI Leisure & Capital Management GmbH | Close relation | Sell | None | 197,193.60 EUR |
2022-04-25 | Bloching, Prof. Dr. Micha | Supervisory board | Sell | None | 171,825.00 EUR |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
![]() |
BOIRON | France | BOI | |
![]() |
Bonyf N.V. | Belgium | MLBON | |
![]() |
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
BrightPath Biotherapeutics Co., Ltd. | Japan | 4594 | ||
|
Calliditas Therapeutics | Sweden | CALTX | |
![]() |
Camurus | Sweden | CAMX | |
CanBas Co.,Ltd. | Japan | 4575 | ||
![]() |
Cannabotech Ltd. | Israel | CNTC |